silybin has been researched along with Rheumatoid Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, SL; Liu, L; Liu, ZQ; Mai, CT; Wang, H; Xie, Y; Zheng, YF; Zhou, H | 1 |
| Alessandri, C; Anticoli, S; Ceccarelli, F; Conti, F; Dupuis, ML; Fragale, A; Gabriele, L; Gagliardi, MC; Maselli, A; Ortona, E; Pagano, MT; Pierdominici, M; Ruggieri, A; Sanchez, M; Valesini, G | 1 |
2 other study(ies) available for silybin and Rheumatoid Arthritis
| Article | Year |
|---|---|
Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Line; Cytokines; Dyslipidemias; Enzymes; Gene Expression Regulation; Hepatocytes; Humans; Lipid Metabolism; Lipogenesis; Liver; Liver X Receptors; Male; NF-kappa B; Rats, Sprague-Dawley; Silybin; Up-Regulation | 2021 |
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
Topics: Aged; Apoptosis; Arthritis, Rheumatoid; Cell Proliferation; Cytokines; Estrogen Receptor beta; Female; Gene Expression Regulation; Humans; Immunity; Immunomodulation; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; MicroRNAs; Middle Aged; Silybin; T-Lymphocytes | 2018 |